Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
第一作者:
Amy S,Paller
第一单位:
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Dermatology, Ann and Robert H Lurie Children's Hospital, Chicago, IL, USA.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);儿童(Child);皮炎, 特应性(Dermatitis, Atopic);皮肤科用药(Dermatologic Agents);糖皮质激素类(Glucocorticoids);人类(Humans);免疫球蛋白A(Immunoglobulin A);药用制剂(Pharmaceutical Preparations);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome);美国(United States)
DOI
10.1016/S0140-6736(22)01539-2
PMID
36116481
发布时间
2022-09-21
- 浏览2
Lancet (London, England)
908-919页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



